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Abstract
Resveratrol has been extensively reported as a potential compound to treat some skin disorders, including skin cancer,
photoaging, allergy, dermatitis, melanogenesis, and microbial infection. There has been an increasing interest in the
discovery of cosmetic application using resveratrol as the active ingredient because of its anti-aging and skin lightening
activities. The naturally occurring derivatives of resveratrol also exert a beneﬁcial effect on the skin. There are four
groups of resveratrol derivatives, including hydroxylated compounds, methoxylated compounds, glycosides, and oligomers. The major mechanism of resveratrol and its derivatives for attenuating cutaneous neoplasia, photoaging and
inﬂammation, are related with its antioxidative activity to scavenge hydroxyl radical, nitric oxide and superoxide anion.
A systematic review was conducted to describe the association between resveratrol-related compounds and their beneﬁts
on the skin. Firstly, the chemical classiﬁcation of resveratrol and its derivatives was introduced. In this review the cases
which were treated for different skin conditions by resveratrol and the derivatives were also described. The use of
nanocarriers for efﬁcient resveratrol skin delivery is also introduced here. This review summarizes the cutaneous
application of resveratrol and the related compounds as observed in the cell-based, animal-based and clinical models.
The research data in the present study relates to the management of resveratrol for treating skin disorders and suggesting a way forward to achieve advancement in using it for cosmetic and dermatological purpose.
Keywords: Antioxidant, Nanocarriers, Naturally occurring derivatives, Resveratrol, Skin

1. Introduction

P

olyphenols are the phytochemicals containing many bioactive compounds, mostly found
in vegetables, fruits and soy [1]. These molecules
can be classiﬁed into 5 major categories, including
hydrobenzoic acids, hydroxycinnamic acids, ﬂavonoids, stilbenes, and lignans [2]. Among these,
resveratrol (3,5,40 -trihydroxystilbene) from the

group stilbenes has gained lot of attention as it
considered to be beneﬁcial for human health. This
compound was ﬁrst isolated from the roots of
Veratrum grandiﬂorum in 1940. It was initially
characterized as a phytoalexin, providing defense
against the attacks from insects and pathogens [3].
This natural phytoalexin is detected in more than
70 different plants such as grapes and berries, and
is also found in human foods and in all kinds of
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red wines. Resveratrol has attracted a lot of interest in 1992 because of a report demonstrating
the cardioprotective activity discovered in red
wine [4]. Resveratrol is a stilbenoid possessing
two phenols linked by an ethylene bridge (Fig. 1).
The chemical structure can be identiﬁed as two
isomers: trans- and cis-resveratrol. The trans form
is found in the plants, while the cis form is produced by isomerization of trans form and as a
result of disintegration of resveratrol oligomers

during the fermentation of grape skin in the
presence of ultraviolet (UV) irradiation [5]. The
trans form generally shows greater bioactivities
than the cis structure.
Resveratrol can act as an antioxidant to modulate
cellular functions. It scavenges hydroxyl radical,
nitric oxide and superoxide anion [6]. The prevention and treatment of oxidative stress-related pathological conditions by resveratrol are largely
investigated. Polyphenol is reported to prevent or
treat cardiovascular disorder, cancer, diabetes

Fig. 1. The chemical structures of resveratrol and its naturally occurring derivatives discussed in this review. There are four groups of resveratrol
derivatives, including hydroxylated compounds, methoxylated compounds, glycosides, and oligomers. The major oligomers with bioactivities on skin
are dimmers, trimers, and tetramers.

mellitus, microbial infection, aging, and inﬂammation [7]. Many resveratrol derivatives have been
found in natural resources. These derivatives exhibit
stilbene skeleton with various substituting moieties.
There are four groups of resveratrol derivatives,
including hydroxylated compounds, methoxylated
compounds, glycosides and oligomers. The resveratrol derivatives also demonstrate biological activities covering wide diversities, such as anticancer,
anti-aging, anti-inﬂammatory and antibacterial effects [8,9]. The predominant problem of resveratrol
and its analogs associated with its applicability on
disease treatment is the low oral bioavailability, as it
gets metabolized via phase II enzymes [10]. In
addition to the low bioavailability, resveratrol has
very short half-life (8‒14 min) and undergoes
extensive metabolism in the circulation [11]. Some
strategies are employed to overcome the issues
related with the low bioavailability. Among these
strategies, skin delivery is a useful alternative of oral
delivery for treating dermatological diseases.
Resveratrol is reported to be readily absorbed
through skin [12]. Additionally, the possible skin
irritation caused by topical resveratrol is also reported to be low [13,14].
Another approach for increasing the applicability
of resveratrol-based therapy is to implement the use
of nanomedicine [15]. Because of the low aqueous
solubility and instability of resveratrol and its derivatives, nanoencapsulation is veriﬁed to be an
efﬁcient way to increase its solubility, bioavailability
and other biological functions. The incorporation of
resveratrol in nanocarriers will help to achieve the
aim of enhanced stability, controlled release and
tissue or organ targeting and therefore causes less
side effects [16]. To increase the skin absorption of
resveratrol, some nanoformulations such as liposomes, niosomes, solid lipid nanoparticles (SLNs),
nanostructured lipid carriers (NLCs), nanoemulsions, polymeric nanoparticles, and dendrimers are utilized to promote the possible
application of topical resveratrol (Fig. 2). Liposomes
and niosomes can be classiﬁed as the nanovesicles
with bilayers and aqueous cores. SLNs, NLCs, and
nanoemulsions are the lipid-based nanocarriers
with lipids in the cores. Polymer-based nanocarriers
include poly(lactic-co-glycolic acid) (PLGA), polylactic acid (PLA), and dendrimers, which are
commonly used in biomedical investigation due to
their safety and tunable size. In the past few decades
a great advancement in the investigation of resveratrol and its derivatives has demonstrated that it
holds signiﬁcant promise for skin use. In this review, we highlight the cutaneous application of
resveratrol and its naturally occurring derivatives
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for treating skin disorders. We mainly focus on the
reports of skin diseases treated by these stilbenoids
using different evaluation platforms, including in
vitro, ex vivo and in vivo examinations. The promising perspective associated with this emerging
application is also discussed in the present study.
The development of nanocarriers for improving the
skin absorption capability and therapeutic efﬁcacy
of topical resveratrol is also introduced in this review article.

2. Chemical structure of resveratrol and its
derivatives
The chemical structure of resveratrol consists of
two phenolic rings which are bonded together by a
double styrene bond. Resveratrol is equipped with
different functional moieties including aromatic ring,
hydroxyl group, and double bond. These groups
offer a great potential to be conjugated with other
moieties for structure modiﬁcations [17]. A large
number of natural resveratrol derivatives are broadly
investigated for their bioactivities. The structures of
these compounds can be divided into hydroxylated
derivatives, methoxylated derivatives, glycosides,
and oligomers (Fig. 1). Some hydroxylated resveratrol derivatives are derived from natural products.
These include oxyresveratrol, piceatannol, and prenyloxyresveratrol. The addition of hydroxyl group in
resveratrol structure can increase the therapeutic
versatility of the parent compound [18]. Oxyresveratrol can be derived from many plants,
showing antioxidant and anti-inﬂammatory potential
[19,20]. Oxyresveratrol has proved to reveal greater
inhibition of tyrosine oxidation catalyzed by tyrosinase (IC50 ¼ 53 mM) than that observed in the parent
compound (IC50 > 100 mM) [21]. Another hydroxylated resveratrol derivative commonly studied is
piceatannol, which possesses an additional hydroxyl
group than resveratrol. Piceatannol is reported to
have antioxidative, anticancer, immunomodulatory
and anti-inﬂammatory effects [22].
The substitution of hydroxyl group by methoxyl
group can increase the structural stability of
resveratrol. The methoxyl resveratrol compounds
demonstrate better bioavailability than the parent
compound because of their higher lipophilicity [23].
The glucuronidation and sulﬁdation of methoxyl
derivatives is less than the parent resveratrol during
metabolism, conﬁrming that methoxylation leads to
stronger bioactivity response. Pterostilbene is a
methoxylated resveratrol isolated from grapes,
blueberries and some plant woods [24]. The anticancer, antilipidemic, and cardioprotective properties of pterostilbene are greater than that observed
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Fig. 2. The structures of nanocarriers used for cutaneous delivery of resveratrol and its naturally occurring derivatives. These nanosystems include
liposomes, niosomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanoemulsions, polymeric nanoparticles, and dendrimers. The detailed description of the structures of these nanocarriers is shown in the text.

in resveratrol [25,26]. It is also reported that 3,4’,5trimethoxystilbene has more potent antioxidant and
proapoptotic activities than that seen in resveratrol
[18]. Another way to increase resveratrol bioavailability is through glycosylation. Glycosylation enhances
resveratrol
solubility
in
aqueous
environment, leading to an improvement in its
bioavailability [27]. The glycosylation process also
prevents enzymatic oxidation which in turn preserves the biological activities and increases the
stability. Polydatin, also known as piceid or resveratrol 3-O-b-D-glucopyranoside, is the most common
resveratrol
glycoside
examined
for
bioactivities. This glycoside shows a structure in
which a glucose is transferred to the C-3 hydroxyl
moiety. Polydatin is abundant in red wine and grape
juice. The concentration of polydatin in red wine is
even higher than that of aglycone [28]. It is also

detected in hop cones, beer and chocolates. Polydatin appears to be more efﬁcacious than resveratrol
in terms of antioxidant capacity because of the reaction linked with its radical form [29].
Resveratrol oligomers are biosynthesized via
regioselective oxidative coupling of 2 to 8 monomers
[30]. The oligomers can be formed through several
self-mergers done by numerous distinct CeC and
CeO binding [31]. At least 92 new resveratrol oligomers have been identiﬁed in plants in the last
decade [32]. These oligomers have been reported to
exert anticancer, antidiabetic, antibacterial and cardiovascular-protective effects [33,34]. The biological
activities of resveratrol oligomers depend upon their
molecular size and stereochemistry. Some studies
[35,36] have demonstrated that the addition of
increasing number of resveratrol units increase the
biological potency and speciﬁcity. It is documented

that the scavenging capacity and metal ion chelating
ability of the oligomers are higher than that of the
monomer by 20- and 1000-fold [33]. The structures
of resveratrol derivatives described in this review
are illustrated in Fig. 1. Table 1 summarizes the
physicochemical properties of these compounds as
predicted by silico molecular modeling. Molecular
volume, estimated lipophilicity (Alog P), hydrogen
bond (H-bond) number and total surface polarity
were also determined using Discovery Studio 4.1
(Accelrys).

3. Skin disorders treated by resveratrol and its
derivatives
Skin is the largest and outermost organ, it provides the most accessible way to administer drugs
and active ingredients. It is also a semipermeable
barrier that protects the body from the external
environment and it also prevents water loss. The
skin of an average adult human covers a surface
region of approximately 2 m2 and receives one-third
of the blood circulation throughout the body. The
largest organ of the human body, the skin, is
composed of three histological layers: epidermis,
dermis, and subcutaneous tissues. The skin delivery

of drugs or active agents is often challenging due to
the outer barrier of the skin. This barrier includes
the stratum corneum (SC) and tight junction (TJ)
[37]. SC, in particular, presents rigid resistance to
the topical delivery of drugs. Successful skin delivery of drugs necessitates distinct characteristics
regarding molecular size and physicochemical
properties. The ideal physicochemical characteristics for facile skin absorption of permeates include
low molecular weight (<500 g/mol), moderate lipophilicity (partition coefﬁcient log P ¼ 1‒3),
adequate solubility in both water and oil, as well as
have a low melting point [38]. Resveratrol and some
of its derivatives ﬁt in these criteria, resulting as the
ideal candidate for topical administration to treat
skin diseases and other abnormalities.
Skin disorder is a commonly found human illness,
affecting about 70% of the population worldwide. It is
the fourth leading cause of disability in the world [39].
For the management of skin diseases by drug therapy, topical administration renders an appealing
approach as it provides various advantages
including, direct nidus targeting, avoidance of systemic toxicity, and non-invasive application [40].
Recent application of resveratrol and its analogs in
skin-related diseases includes therapies for skin

Table 1. Anti-skin cancer activity of resveratrol and its derivatives.
Compound

Experimental model

Cell or animal type

Outcomes offered by the
compound

Reference

Resveratrol

In vitro SCC

Colo-16 cells

[68]

Resveratrol

In vitro SCC

Ca3/7 cells

Resveratrol

In vivo phorbol ester induction

ICR mouse

Resveratrol

In vivo phorbol ester induction

ICR mouse

Resveratrol

In vivo DMBA induction

Albino mouse

Resveratrol

In vitro melanoma

B16eF10 and A375 cells

Resveratrol

In vitro in vivo melanoma

DM738 and DM443 cells

e-Viniferin and pallidol

In vitro melanoma

HT-144 and SKMEL-28 cells

e-Viniferin and labruscol

In vitro melanoma

HT-144 and SKMEL-28 cells

Resveratrol in liposomes

In vitro melanoma

SKMEL-28 and Colo-38 cells

Resveratrol in polymeric
nanoparticles

In vitro melanoma and in
vivo phorbol ester induction

B16eF10 cells and mouse

Cell growth inhibition via
Wnt signaling
Synergistic effect with ursolic
acid
Tumor suppression by COX-2
inhibition
Tumor suppression via NF-kB
and AP-1 pathways
Tumor suppression via PI3K
and protein kinase B
regulation
Apoptosis via PI3K and
protein kinase B regulation
Synergistic effect with
temozolomide
e-Viniferin displayed a
greater melanoma inhibition
than resveratrol and pallidol
Melanoma inhibition via cell
cycle blocking in S phase
Ultradeformable liposomes
enhanced cytotoxicity and
percutaneous permeation
Nanoparticles enhanced
cytotoxicity and in vivo tumor
incidence

[69]
[71]
[72]
[73]

[75]
[76]
[77]

[78]
[80]

[81]

AP-1; activator protein-1; COX-2, cyclooxygenase-2; DMBA, 7,12-dimethylbenz[a]anthracene; NF-kB, nuclear factor-kB; PI3K, phosphatidylinositol-3-kinase; SCC, squamous cell carcinoma.
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Fig. 3. The skin diseases that can be ameliorated by resveratrol and its naturally occurring derivatives in cell- or animal-based studies. The possible
signaling pathways for the treatment of these skin disorders are summarized in this ﬁgure. Resveratrol and its analogs demonstrate antioxidant,
anticancer, antiaging, anti-inﬂammatory, anti-melanogenesis, and antimicrobial impacts for skin application.

cancers, photoaging, intrinsic aging, cutaneous
inﬂammation, melanogenesis, and microbial infection (Fig. 3). The possible mechanisms involving in
the bioactivity of resveratrol and its analogs are also
illustrated in this ﬁgure. The use of these active
compounds can ameliorate the symptoms of the skin
diseases. Some therapies based on resveratrol properties have been approved for clinical use or are
under clinical trial for preventive or therapeutic use.
In addition, some resveratrol or the derivatives are
approved to manage various skin diseases in cellbased and animal studies. Some of these resveratrolrelated compounds are included in topical formulations for cosmetic purposes [41].
Skin cancer is the most common form of cancer,
globally accounting for at least 40% of cancer cases
[42]. There are three major types of cutaneous tumors,
including basal cell carcinoma (BCC), squamous cell
carcinoma (SCC) and melanoma. The ﬁrst two can be
classiﬁed as non-melanoma skin cancers (NMSC).
Mohs micrographic surgery (Mohs surgery) is a
technique used to remove the cancer with the least
amount of surrounding tissue and the edges are

checked immediately to see if any tumor is detected.
For low-risk diseases, radiation therapy, topical
chemotherapy and cryotherapy can provide
adequate control of the disease [43]. The topical
chemotherapy is also used for the prevention of
tumor recurrence after surgical removal. Some
polyphenolic compounds such as phenolic acids,
ﬂavonoids, stilbenes, and lignans have proved to be
effective for mitigating the tumor growth of NMSC
and melanoma [44]. These compounds act on several
biomolecular pathways including, cell division cycle
arrest, autophagy, and apoptosis. Cutaneous aging
can be divided into photoaging and chronological
aging. Photoaging is activated via the human skin
damage attributable to repeated UV exposure from
sunlight. Exposure to UV radiation from the sun is the
main risk factor for causing skin cancer [45]. UV elicits
both acute and chronic adverse effects on the skin.
These include sunburn, photosensitivity, inﬂammation, immunosuppression, and photocarcinogenesis
[46]. UV exposure of the skin creates reactive oxygen
species (ROS), leading to the massive inﬁltration of
immune cells such as neutrophils and macrophages
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Fig. 4. The morphologies and features of psoriasis and atopic dermatitis skins. Typical histologic features of psoriasis includes epidermal hyperplasia
with elongated rete ridges, a less discrete epidermal granular layer, parakeratosis, and leukocyte inﬁltration of the viable skin. Dermatitis is an
inﬂammatory skin disease characterized by presence of erythema, edema, vesicles, and licheniﬁcation. The effects of resveratrol and its analogs on
psoriasis and dermatitis for ameliorating the signs and symptoms are summarized in this ﬁgure.

in viable skin cells [47]. Due to its antioxidant property, resveratrol and its derivatives have the capability to ameliorate cutaneous photoaging.
Inﬂammatory skin diseases are the most common
problem in dermatology. They can range from occasional rashes accompanied by skin itching and
redness, to chronic conditions such as psoriasis,
dermatitis, and rosacea. Both psoriasis and atopic
dermatitis (AD) are autoimmune diseases affecting
skin. Psoriasis, a chronic inﬂammatory disease of
the skin, affects approximately 125 million people
globally [48]. Clinically, psoriasis is characterized by
red plaques with silver or white multilayered scales
with a thickened acanthotic epidermis in patients
who are markedly demarcated from adjacent nonlesional skin (Fig. 4) and its lesions often occur at
sites of epidermal trauma, such as the elbows and
knees, the back, and the trunk, but it can appear
anywhere on the body, which severely impairs patients’ quality of life [49]. Typical histologic features
of psoriasis includes epidermal hyperplasia with
elongated rete ridges, a less discrete epidermal
granular layer, parakeratosis, and leukocyte inﬁltration of the viable skin. More than 80% of patients
show a mild-to-moderate level of severity [50],
which can be controlled by topical therapy. However, conventional topical-application treatment is
usually time-consuming with incomplete lesion
resolution and some adverse effects. The

development of new topically applied agents is
deﬁnitely needed, especially the ones discovered
from natural resources [51]. Some natural compounds are useful for treating psoriasis because of
their antioxidant, anti-inﬂammatory and apoptotic
activities [52].
AD is an inﬂammatory skin disease characterized
by presence of erythema, edema, vesicles, and
licheniﬁcation (Fig. 4). The pathogenesis of AD involves dysregulation in the inﬂammatory process
and a change in response to antigens. The prevalence of AD has increased 3-fold over the past 30
years because of environmental risks [53]. It is a
common skin disorder affecting 10‒25% of children
and 2‒10% of adults [54]. The anti-AD drugs such as
coal tar, doxepin, calcineurin inhibitors and steroids
are reported to cause skin itching and stinging
sensation [55]. The excessive use of topically applied
calcineurin inhibitors may elicit systemic absorption, therefore, causing toxicity and increasing the
malignancy risk. Corticosteroids are usually
accompanied by side effects such as skin thinning,
striae, corticophobia and also demonstrate insufﬁcient clinical response [56]. The development of new
agents for AD treatment is urgently needed to
minimize these side effects and enhance the efﬁcacy. Several investigations assessing anti-AD
therapy based on natural sources have revealed
some potential activities in this area [57]. There are
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two important features associated with AD that
make it difﬁcult to treat. Firstly, it compromises the
skin barrier and secondly, increases the risk of
cutaneous infection. As the integrity of barrier is
reduced this leads to Staphylococcus aureus invasion
and exacerbates eczema [58]. More than 90% of AD
patients are colonized with S. aureus [59]. The bacterial population increases in the skin involving lesions of AD and chronic wounds. Hence it plays a
critical role in infection-induced inﬂammation and
cutaneous disease progression [60]. Polyphenols
including resveratrol-related compounds can be
used to treat cutaneous and subcutaneous infections
caused by bacteria and fungi [61,62].
Resveratrol and its derivatives are also investigated for skin hyperpigmentation treatment. These
compounds can act as skin lightening agents to
improve skin aesthetics. Hyperpigmentation occurs
when the skin releases more melanin content.
Melanin is the pigment which gives skin its color.
This can make spots or patches of skin appear
darker than surrounding areas. Hyperpigmentation
can occur after an injury or due to skin inﬂammation caused during cuts, burns, acne, and lupus.
Excessive sun exposure and melasma can also cause
hyperpigmentation [63]. Tyrosinase is regarded as a
key enzyme implicated in the metabolism of
melanin in melanocytes and its inhibitors have
become increasingly important in medicinal and
cosmetic products in relation to hyperpigmentation.
Resveratrol has been already proved as a tyrosinase
inhibitor which can reduce the cutaneous pigmentation [64].

4. Resveratrol and its derivatives as the active
agents for skin-related disease therapy
The following review describes the different
therapeutic and cosmetic approaches of resveratrol
and its analogs on skin. These include the cell-based
study, animal-based study and clinical human trial.
The pharmacodynamics outcome of these compounds are the main evaluation platform used to
deﬁne the preventive or therapeutic effects in our
present description.
4.1. Skin cancers
Chemotherapy or chemoprevention by natural
compounds is appreciated as a new strategy in the
management of carcinomas including skin cancers.
The anticancer ability of resveratrol is veriﬁed by in
vitro and in vivo evaluations. The tumor inhibition
by resveratrol involves its antioxidant, anti-inﬂammatory, antiproliferative and pro-apoptotic activities

[65]. Resveratrol can suppress carcinogenesis at
different stages, including initiation, promotion, and
progression [66]. SCC is a common form of skin
cancer which develops in the squamous cells that
make up the middle and outer layers of the skin. It is
usually found in areas of the skin damaged by
excessive UV exposure from the sun. Surgery is the
ﬁrst choice for treating SCC, whereas the adjuvant
therapy by chemotherapy can improve the survival
rate and life's quality. Wnt/b-catenin signaling is
activated in the process of development of SCC [67].
The effect of resveratrol on cell growth and how it
impacts Wnt signaling of SCC Colo-16 cells was
investigated by Liu et al. [68]. The concentration of
resveratrol that inhibited 50% of SCC cell growth
(IC50) was 114 mM. It was reported that Wnt2
expression was downregulated accompanied by
increased expression of Wnt inhibitor Axin2. It was
suggested that the inactivation of Wnt pathway was
the main target of resveratrol associated with
restraining SCC growth. Resveratrol can also be
used as an enhancer to synergize anti-SCC activity
of ursolic acid [69]. Ursolic acid is approved as an
efﬁcient natural compound to induce death of skin
cancer cell lines via AMP-activated protein kinase
[70]. Resveratrol if used at a concentration of 25 mM
enhances antiproliferative effects of ursolic acid in
the Ca3/7 cell lines in a dose-dependent fashion.
The IC50 of ursolic acid could be reduced by 2.3-fold
after the co-treatment with resveratrol at 100 mM.
An earlier study [71] has investigated the impact
of resveratrol on phorbol ester-induced skin cancer
in mouse. Phorbol ester can be used as an activator
to induce NMSC-like model. Aberrant cyclooxygenase (COX)-2 expression is an indicator of
tumor promotion. It was seen that the topical delivery of resveratrol at 1 mmol, 30 mins prior to
phorbol ester treatment decreased COX-2 level in
mouse skin. Phorbol ester intervention resulted in
the induction of IkB kinase activity in skin, which
could be abolished by topical application of resveratrol. Besides IkB kinase, the COX-2 upregulation in
the skin cancer is activated via nuclear factor (NF)kB that is regulated by mitogen-activated protein
kinase (MAPK). Kundu et al. [72] found that topical
resveratrol inhibited NF-kB and activator protein
(AP)-1 activities in phorbol ester-induced skin
tumor. Both signal pathways could be the prime
targets of resveratrol to inhibit skin cancer. In a
study, the chemopreventive effect of topical
resveratrol was also examined in the 7,12-dimethylbenz[a]anthracene (DMBA)-induced mouse
skin tumor [73]. Topical resveratrol treatment was
given to mice 1 hour before initiating DMBA treatment for 28 weeks. The induction of ﬁrst tumor was

detected after 52 days with regard to the vehicle
control. The onset could be delayed by 73 to 79 days
after receiving resveratrol at a dosage of 25 and 50
mM respectively. Resveratrol administration at 25
mM and 50 mM led to a reduction in tumor volume
by 51% and 65% respectively. This inhibition by
resveratrol was conﬁrmed due to the involvement of
phosphatidylinositol-3-kinase (PI3K) and protein
kinase B.
Melanoma is a type of skin cancer characterized
by an aggressive pathogenesis and poor response
to therapy. Cutaneous melanoma originates from
genetically altered melanocytes in the epidermal
basal layer. It is reported that some polyphenols
such as curcumin, quercetin, coumarin and
resveratrol display antioxidant, anti-inﬂammatory
and antiproliferative efﬁcacies to inhibit melanoma
[74]. In a cell-based assay [75], murine melanoma
(B16eF10) and human melanoma (A375) cell lines
were used as the models to examine the effect of
resveratrol on melanoma. Resveratrol at a dose of
100 mM increases apoptosis of both cell lines by 4‒
6-fold as compared to that of the control. The
autophagy-related proteins including Beclin 1 and
microtubule-associated protein 1A/1B-light chain 3
(LC3)-II/I were upregulated after resveratrol
treatment. Phosphorylated PI3K and protein kinase B were also reduced by this compound. Since
autophagy is vital for the growth of malignancies,
the results have led to the development of targeted melanoma treatment by resveratrol.
Osmond et al. [76] conducted in vitro and in vivo
cytotoxicity of resveratrol against melanoma cell
lines, DM738 and DM443. Resveratrol treatment at
doses of <50 mM manifested a dose-dependent
cytotoxicity, whereas the doses between 50 mM
and 100 mM showed no additional effect. It is
demonstrated that resveratrol also signiﬁcantly
enhances cytotoxicity of temozolomide, an antimelanoma drug. The mouse with subcutaneous
DM738 xenograft was treated with resveratrol (90
mg/kg) 2 days prior to initiating temozolomide
treatment. The results showed that cyclin B and
D1 were reduced by resveratrol after a 2-day
treatment.
e-Viniferin and pallidol are the dimers of resveratrol. Nivelle et al. [77] found that pallidol revealed
a comparable inhibition of the growth of melanoma
cell lines, namely HT-144 and SKMEL-28 which are
similar to that observed with resveratrol treatment.
The dehydrodimer e-viniferin showed considerably
higher inhibition than resveratrol and pallidol. The
IC50 of e-viniferin against HT-144 and SKMEL-28
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was 18 mM and 16 mM respectively which was lower
than that of resveratrol and pallidol (>100 mM). The
mechanisms behind anti-melanoma activity of eviniferin were further explored in the cell-based
study [78]. Another dimer, labruscol, was also
employed for comparison. The IC50 of e-viniferin
and labruscol against HT-144 metastatic cells in the
presence of fetal bovine serum was 65 mM and 54
mM respectively. Labruscol induced more necrosis
(40%) in HT-144 metastatic cells as compared to eviniferin (25%) and resveratrol (18%). All these
compounds blocked cell cycle of melanoma during
S phase by modulating cell cycle regulators such as
cyclin A, E, and D1. It was reported that this effect
demonstrated no cytotoxicity on normal dermal
ﬁbroblasts.
Nanocarriers are used to load resveratrol for
enhanced skin delivery to treat skin cancers. Ultradeformable liposomes are forms of nano-sized vesicles consisting of phospholipids and edge activator,
capable of increasing the ﬂexibility of liposomal bilayers to squeeze into SC [79]. Cosco et al. [80]
prepared the ultradeformable liposomes with a
mean diameter of <120 nm. The co-entrapment of
resveratrol and 5-ﬂuorouracil in ultradeformable
liposomes increases the cytotoxicity more against
SKMEL-28 and Colo-38 cells than that observed
with free compounds and single compounds in liposomes. This nanoformulation arrested cell proliferation in G1/S phase. The skin permeation of
resveratrol and 5-ﬂuorouracil across human
epidermis was increased by 8.3- and 6.2-fold
respectively after liposomal encapsulation. Bano et
al. [81] developed polymeric nanoparticles made
with poly (N-isopropylacrylamide) (PNIPAAM)polyethylene glycol (PEG) encapsulated with
resveratrol for evaluating inhibitory efﬁcacy on skin
cancer. The nanoparticle size was around 100 nm
with a high resveratrol encapsulation percentage of
>80%. The loading of resveratrol into nanoparticles
decreased B16eF10 cell viability from 60% to 40%.
In the promotion phase of in vivo skin cancer
induced by phorbol ester, a signiﬁcant reduction
was found in tumor incidence and tumor burden in
mice which were pretreated with nanoparticles. The
percentage of mice with tumors was 82% after
intervention. This percentage was reduced to 19%
and 6% by treatment with free resveratrol and
resveratrol-loaded nanoparticles respectively. The
nanocarriers upregulated Bax expression, leading to
the apoptosis of the phorbol ester-induced tumor.
The anti-skin cancer activity of resveratrol and its
analogs is summarized in Table 1.
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4.2. Extrinsic aging and photoaging
Skin aging is divided into intrinsic and extrinsic
modes. Extrinsic and intrinsic aging is caused by
environmental and genetic factors respectively [82].
Extrinsic skin aging can be induced by UV exposure,
smoking, air pollution and poor nutrition. Intrinsic
aging, also named as chronological aging, is a slow
biological process characterized by ﬁne wrinkling,
fragility, reduced elasticity, loss of skin tone and
mottled pigmentation [83]. Polyphenols can be used
as antioxidants to treat skin aging because of the
capability to donate hydrogen atoms which helps to
neutralize free radical species produced during
oxidative stress [84]. The free radicals are formed
under the inﬂuence of UV exposure, toxins, and
smoking. Sirtuin is an enzyme that is associated
with regeneration, vitality, and resistance of the
mammalian cells. The activity of sirtuin decreases
with the increase in age [85]. Resveratrol can slow
the process of skin aging due its role as a sirtuin
activator and free radical scavenger [86]. Topical
delivery is beneﬁcial to replenish resveratrol in skin,
resulting in the efﬁcient prevention of skin aging
and damage by oxidative stress. Alonso et al. [87]
compared the antioxidative effect of ﬁve polyphenols on skin after their topical application. The
polyphenols included epicatechin, quercetin, rutin,
trolox and resveratrol. Polyphenols were extracted
from the pig skin treated by topically applied polyphenols using Franz cell assembly. 1,1-Diphenyl-2picrylhydrazyl (DPPH) assay was used to determine
antioxidant activity. Among the polyphenols, rutin
and resveratrol were observed to be more favorable
for inhibiting DPPH. Resveratrol deposition in
epidermis was 2.02 nmol/cm2, which was much
higher than rutin (0.66 nmol/cm2), indicating a
satisfactory percutaneous absorption of resveratrol.
The skin absorption of resveratrol was further
investigated in the in vivo human model [88]. Six
volunteers who participated in this study received
topically applied resveratrol (500 mg/cm2) on the
forearm surface. The results showed that the major
amount (77%) of permeated compound was located
in the upper SC layer. The DPPH inhibition caused
by resveratrol which was deposited in SC layer was
28%.
The UV radiation is the main etiological factor
which elicits premature skin aging. It is also the
major cause behind skin cancer [89]. To prove the
photoprotective properties of resveratrol on skin,
Park and Lee [90] treated UVB-irradiated HaCaT
keratinocytes by resveratrol. It was observed that
pretreatment by resveratrol at the doses of 5‒100
mM markedly increased keratinocyte survival in the

presence of UVB. The ROS production was also
attenuated by resveratrol pretreatment. The activation of caspase-3 and -8 was inhibited in resveratroltreated (100 mM) HaCaT keratinocytes by one and a
half times. In an in vivo hairless mouse model,
topical resveratrol (10 mmol per mouse) was applied
on the dorsal skin exposed to UVB at 180 mJ/cm2
[91]. The ﬁndings demonstrated that UVB increased
skin thickness (2-fold), cyclin-dependent kinase-2
(cdk) (3-fold), cdk-4 (3 fold), cdk-6 (4-fold), cyclin D1
(2-fold), and cyclin D2 (2-fold) in epidermis.
Resveratrol could downregulate these cell cycle
regulatory proteins, suggesting the antiproliferative
activity of resveratrol on photoaged skin. Aziz et al.
[92] further veriﬁed the primary role of survivin, the
inhibitor of apoptosis protein family, on resveratrolmediated protection from UVB in hairless mouse
model. It was seen that UVB light signiﬁcantly
upregulated survivin expression in skin. In the
UVB-exposed mouse topical pretreatment of
resveratrol, at a dose of 10 mmol, resulted in the
inhibition of survivin protein by two-third.
Pterostilbene is a methoxylated resveratrol with
potent antioxidative activity. The inhibitory effect of
pterostilbene on UVB-induced photodamage in
keratinovytes was investigated in a study [93].
HaCaT keratinocytes were pretreated with pterostilbene at a dose of 5 or 10 mM prior to UVB
irradiation (300 mJ/cm2). Pterostilbene attenuated
UVB-evoked cell death and ROS generation. The
nuclear translocation of nuclear factor erythroid 2related factor 2 (Nrf2) and the Nrf2-dependent
antioxidant enzymes were increased after pterostilbene intervention. Nrf2 pathway exerts a critical
role in promoting defense against oxidative stress
[94]. SKH-1 hairless mouse was used as the in vivo
model to test whether pterostilbene was effective for
treating UVB-induced skin disruption [95]. Topical
application of pterostilbene demonstrated a dramatic decrease in UVB-evoked skin tumorgenesis
(90% tumor-free animals) after 40 weeks, whereas
resveratrol showed no such effect (0%). The results
highlighted that pterostilbene could suppress
oxidative damage caused by UVB but resveratrol is
unable to do so. Pterostilbene maintained a high
level (150 mmol/kg) in the skin after a 6-h topical
administration at a dose of 1 mmol/cm2. Polydatin is
a resveratrol glycoside displaying strong antioxidative activities. He et al. [96] demonstrated that
polydatin protects the skin from UVB-induced
damage as seen in both in vitro and in vivo experiments. There was no cytotoxicity noticed in HaCaT
cells, treated with polydatin at a dose up to 100 mg/
ml. UVB exposure at 30 mJ/cm2 led to 43% HaCaT
cell death compared to that of the control. Polydatin

reduced the cell death and ROS production elicited
by UVB in a dose-dependent manner (0‒80 mg/ml).
The ﬁndings of the study conﬁrmed that UVB irradiation (360 mJ/cm2) on nude mouse skin resulted in
desquamation and erythema and topical delivery of
polydatin (10 mg/ml) could reverse these symptoms.
The results showed that the epidermal thickness is
increased by UVB (87 mm) and decreased by using
polydatin (38 mm). In addition to the role of antioxidant, polydatin acted as a sunscreen to retard UVBinduced photoaging. Matrix metalloproteinase
(MMP)-1 plays a major role and is involved at
multiple stages of skin photoaging [97]. Some
resveratrol oligomers derived from Vatica albiramis
have proved to exert the ability to arrest MMP-1 in
dermal ﬁbroblasts [36]. IL-1b initiated MMP-1 production from human foreskin ﬁbroblasts. Three
oligomers including ()-hopeaphenol, vaticanol C
and stenophyllol C exhibited signiﬁcant inhibition
on MMP-1. These oligomers were tetramers.
Resveratrol dimers had negligible or very less activity associated with the suppression of MMP-1
release.
Like the ultradeformable liposomes, transfersomes and ethosomes are elastic nanovesicles
used for improving skin delivery of the bioactive
agents [98]. Transfersomes consist of surfactants
such as polysorbate 80, sodium cholate, and sodium deoxycholate which helps to increase the
phospholipid bilayer ﬂexibility. Nanovesicles are
composed of phospholipids, water and ethanol,
they form ethosomes which interacts with SC layer.
Scognamiglio et al. [99] prepared transfersomes
and ethosomes for loading resveratrol. The prepared nanovesicles showed mean diameters between 83 and 116 nm with a high resveratrol
encapsulation of >70%. H2O2 treatment on HaCaT
cells increases ROS production. This elevation was
inhibited by polysorbate 80-incorporated (62%),
sodium cholate-incorporated (62%), and sodium
deoxycholate-incorporated (48%) transfersomes
loaded with 2 mg/ml resveratrol. It was seen that the
ROS reduction by ethosomes was only 23%. The in
vitro study involving pig ear skin permeation
demonstrated that only ethosomes could increase
resveratrol delivery across the skin. Wu et al. [100]
also prepared resveratrol-loaded transfersomes
which were incorporated with polysorbate 20,
polysorbate 80, or Plantacare 1200 UP. The vesicle
size ranged between 43 and 81 nm. The antioxidant
activity as determined by DPPH and 2,20 -azinobis(3-ethylbenz
thiazoline-6-sulphonic
acid)
(ABTS) assays revealed a comparable inhibition
associated with free resveratrol. However, the in
vitro permeation study showed that polysorbate 20-
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incorporated transfersomes enhanced resveratrol
delivery by 28%. Lipid nanocarriers, such as SLNs,
NLCs, and nanoemulsions, appear to be suitable as
drug-carrier systems due to their very low cytotoxicity as compared to polymeric nanoparticles
[101]. The predominant difference among SLNs,
NLCs and nanoemulsions is related to the
composition of the inner core. SLNs are particles
that are made from crystalline solid lipids, whereas
NLCs are composed of a solid lipid matrix with a
certain content of liquid lipid; they are a more
advanced generation of SLNs. Nanoemulsions are
nanocarriers with neat liquid oil in the inner phase.
Gokce et al. [102] in a study entrapped resveratrol
into SLNs and NLCs to examine its antioxidative
effect and skin absorption capacity. The average
size of SLNs and NLCs was 287 and 111 nm
respectively. The smaller size of NLCs with a
reduced negative surface charge favored endocytosis into dermal ﬁbroblasts, resulting in less ROS
production than that observed in SLNs. In the in
vitro study, rat skin absorption indicated a higher
resveratrol deposition in epidermis by application
of NLCs (1.99 mg/cm2) than that seen with SLNs
(1.55 mg/cm2).
4.3. Intrinsic aging and cosmetic use
Intrinsic skin aging is caused by senescence and
other intrinsic factors which leads to skin atrophy.
Presence of wrinkles, collagen loss, decreased hydration and skin thinning are the symptoms
commonly observed in the aged skin. Oxidative
stress is strongly associated with skin aging
because of the progressive accumulation of ROS in
skin, as age increases [103]. Natural antioxidants
are used in the production of pharmaceutical or
cosmetic formulations with the aim of delaying the
skin aging process and ameliorating skin aesthetics
[104]. Gnetum gnemon (melinjo) is an arboreal
dioecious plant extensively cultivated in South
Asia. The seeds of this plant are abundant in
resveratrol and its glycosides and dimers [105].
Watanabe et al. [106] evaluated the protective effects of melinjo seed extract on age-related skin
pathology as demonstrated in mouse. Superoxide
dismutase 1 (SOD1) is an enzyme that is essential
for the maintenance of skin homeostasis. The seed
extract or resveratrol was orally administered to
Sod/- mice daily for 12 weeks. The treatment that
was conducted by using extract or resveratrol
reversed skin thinning associated with increased
oxidative damage in Sod/- mice. The gene
expression of Sirt1 in skin was upregulated by the
usage of extract and resveratrol. The in vitro
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experiment also veriﬁed that resveratrol could
elevate the viability of Sod/- ﬁbroblasts.
Resveratrol and its derivatives showed beneﬁcial
outcomes when added into the skincare products.
Some clinical trials are being conducted to test the
improvement associated with skin aging by resveratrol-related products. A clinical study was carried
out in 20 subjects over a period of 6 weeks, receiving
topically applied resveratrol (0.007%)-containing oilin-water cold cream [107]. The skin hydration was
assessed in both the groups (with or without
resveratrol intervention). The results showed that
the hydration level was increased up to 2-fold as
compared to the vehicle control after resveratrol
was applied for 4 weeks. Resveratrol permeated into
the epidermis to supplement the lipids and protective layers, increasing the moisturizing and tightening characteristics. Another clinical study was
performed among 50 volunteers who received dietary supplement of grape fruit extract, rich in
resveratrol and procyanidins for estimating skin
condition [108]. It is important to note that 133 mg of
extract contains 8 mg of resveratrol and 14.63 mg of
procyanidins. The study results showed that skin
moisturization and elasticity had been improved by
the dietary supplementation as measured by
bioengineering techniques, while the skin roughness and wrinkling also reduced. The antioxidant
capacity detected by oxyadsorbent assay showed a
signiﬁcant improvement in the treated group than
that of the placebo group.
Pterostilbene (0.4%) loaded in cream was topically
applied for 8 weeks on 38 volunteers in an open-label,
single-arm study [109]. The skin hydration, brightness, elasticity were examined by bioengineering
methods to achieve quantiﬁable results. The ﬁndings
showed that pterostilbene cream successfully
reduced wrinkles and ﬁne lines. The skin moisturization and elasticity were also improved with no
demonstration of adverse effects. A signiﬁcant
improvement in skin fairness was observed according to the subjective assessment conducted by dermatologists. Lipid-based nanoparticles such as SLNs,
NLCs, and nanoemulsions have proved to exert
occlusive effect, enhancing skin hydration [110].
Montenegro et al. [111] evaluated the capability of
cutaneous hydration as increased by SLNs, NLCs and
nanoemulsions, encapsulated with 1% resveratrol.
The nanoparticle diameters of SLNs, NLCs and
nanoemulsions were 46, 26, and 27 nm respectively.
The prepared nanocarriers were incorporated in the
hydrogels to be applied on the forearm of 12 healthy
subjects for one week. An increase in skin hydration
was detected for all nanocarriers with a tendency of
SLNs > NLCs > nanoemulsions. This could be due to

the higher degree of crystallinity seen in SLNs than
that observed in the other nanosystems which led to a
better occlusion effect. The inhibitory effect of
resveratrol and its natural derivatives on extrinsic
and intrinsic aging is listed in Table 2.
4.4. Skin inﬂammation and autoimmune diseases
Skin appears to act not only as the sensor during
stressful conditions (toxin, pathogen, UV), but also
plays a major role in conducting an orchestrated
recruitment and promoting function of the immune
cells which are involved in inﬂammation. Inﬂammation is central to the pathogenesis of some skinrelated diseases such as eczema, psoriasis, dermatitis, vitiligo, and lupus erythematosus [112].
Resveratrol is a molecule that can mitigate skin
inﬂammation, including autoimmune diseases [113].
Resveratrol targets some of the molecules such as
COX-2, 5-lipoxygenase, and protein kinase B and is
associated with the ability to suppress COX-1 or
COX-2 activity [114]. Resveratrol was able to restrain
keratinocyte proliferation through the inhibition of
aquaporin 3, a vital cell survival regulator [115]. This
inhibition occurred due to SIRT1 activation, resulting in the increased activation of aryl hydrocarbon
receptor nuclear translocator (ARNT). This led to
extracellular
signal-regulated
kinase
(ERK)
dephosphorylation, preventing aquaporin 3 activation. This inhibition process caused by resveratrol
implicated that it can be used to treat hyperplastic
skin disorders such as psoriasis.
Kjaer et al. [116] examined the impact of orally
administered resveratrol on imiquimod-induced
psoriasiform skin in mouse. Resveratrol was given
at a dose of 400 mg/kg per day. Skinfold thickness
increased from 0.55 to 0.82 mm after imiquimod
intervention. This is a typical sign of psoriasis
development. It was observed that oral resveratrol
reduced the thickness to 0.71 nm. The results presented that the severity of scaling and erythema
evoked by imiquimod could be alleviated by
resveratrol. In addition, the gene expression of IL17A, IL-19, and IL-23p19 in skin which was
increased by imiquimod was downregulated after
resveratrol treatment. Besides inducing skin cancer,
12-O-tetradecanoylphorbol-13-acetate (TPA) can act
as a stimulator eliciting psoriasis-like lesion in
mouse because of its capability to cause hyperplasia
and evoke inﬂammatory cell inﬁltration [117].
Murakami et al. [118] used TPA to induce acute skin
inﬂammation in the ear skin of the mouse for
examining whether resveratrol could reduce the
inﬂammatory response. The skin thickness which
was increased by TPA (0.30 mm) could be

Table 2. Extrinsic and intrinsic aging treated by resveratrol and its derivatives.
Compound

Experimental model

Cell or animal type

Outcomes offered by the compound

Reference

Resveratrol

In vitro skin absorption

Pig

[87]

Resveratrol

In vivo skin absorption

Human

Resveratrol

In vitro photoaging

HaCaT cells

Resveratrol

In vivo photoaging

Hairless mouse

Resveratrol
Pterostilbene

In vivo photoaging
In vitro photoaging

Hairless mouse
HaCaT cells

Pterostilbene

In vivo photodamage

Hairless mouse

Polydatin

In vitro and in vivo
photoaging

HaCaT cells and
nude mouse

Oligomers

In vitro IL-1b-induced
aging

Dermal ﬁbroblasts

Resveratrol in
transfersomes and
ethosomes
Resveratrol in
transfersomes
Resveratrol in SLNs and
NLCs
Resveratrol

In vitro H2O2 treatment

HaCaT cells

Resveratrol showed a satisﬁed skin
absorption to exert antioxidative
activity
Topically applied resveratrol mainly
located in SC layer
Resveratrol increased cell survival
and attenuated ROS in UVB-treated
cells
Resveratrol downregulated cell cycle
regulatory proteins
Resveratrol downregulated survivin
Resveratrol attenuated UVB-evoked
cell death and ROS generation via
Nrf2 signaling
Pterostilbene showed superior
oxidative damage inhibition than
resveratrol
Polydatin as the antioxidant and
sunscreen to inhibit UVB-induced
skin damage
()-Hopeaphenol, vaticanol C,
stenophyllol C exhibited signiﬁcant
inhibition on MMP-1
Ethosomes reduced ROS production
and increased resveratrol absorption

In vitro skin permeation

Strat-M membrane

In vitro H2O2 treatment
and skin permeation
In vivo skin atrophy

Dermal ﬁbroblasts
Sod/- mouse

Resveratrol

In vivo skin hydration

Human

Resveratrol and
procyanidins

In vivo skin hydration and
elasticity

Human

Pterostilbene

In vivo skin hydration and
brightness

Human

Resveratrol in SLNs,
NLCs, and
nanoemulsions

In vivo skin hydration

Human

Transfersomes increased resveratrol
delivery
NLCs showed greater ROS
reduction than SLNs
Resveratrol reversed skin thinning
via Sirt1 upregulation
Resveratrol increased skin hydration
by 2-fold
Skin moisturization and elasticity
were increased by dietary
supplementation
The skin moisturization and
elasticity were improved with no
adverse effects
An increase of skin hydration was
detected with a tendency of SLNs >
NLCs > nanoemulsions

[88]
[90]

[91]
[92]
[93]

[95]

[96]

[36]

[99]

[100]
[102]
[106]
[107]
[108]

[109]

[111]

IL, interleukin; MMP-1, matrix metalloproteinase-1; NLCs, nanostructured lipid carriers; Nrf2, nuclear factor erythroid 2-related factor 2;
ROS, reactive oxygen species; SC, stratum corneum; SLNs, solid lipid nanoparticles; Sod: superoxide dismutase; UVB, ultraviolet B.

diminished to 0.21 mm by topical resveratrol delivery. This thickness approximated the healthy
control (0.22 mm) group. It was reported that ear
weight was signiﬁcantly lesser in the topical
resveratrol group (6.3 mg) as compared to the TPA
treated group (9.4 mg).
Resveratrol-enriched rice is developed by genetic
engineering to combine the properties of resveratrol
and rice [119]. Kang et al. [120] used dinitrochlorobenzene (DNCB)-induced AD-like mouse
model to evaluate the amount of inﬂammatory inhibition caused by resveratrol-enriched rice. The
rice intake reduced scratching frequency, dermatitis
severity, and transepidermal water loss (TEWL) in

the DNCB-treated mouse. Topical treatment with
the rice remarkably decreased immunoglobulin E
level by 80%. In the cell-based analysis, the rice and
resveratrol inhibited IL-1b and IL-6 expression in
HaCaT cells with a negligible cytotoxicity. Sozmen
et al. [121] also assessed the effects of orally delivered resveratrol (30 mg/kg per day) on dinitroﬂuorobenzene (DNFB)-induced AD-like lesion. The
results demonstrated that DNFB treatment elevated
epidermal thickness of Balb/c mouse from 20 to 97
mm. This thickness elevation was lowered to 41 mm
by resveratrol usage. IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) are released from keratinocytes to activate Th2-type immune response.
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According to immunohistochemical analysis, the
number of these proteins in epidermis was lower in
resveratrol-treated group than that where only
DNFB treatment was conducted. Shen and Xu [122]
also found that oral resveratrol (25 mg/kg) downregulated Th2-type cytokines such as IL-4, IL-5, and
IL-13; and Th1-type cytokines such as IL-12 and
interferon-g in DNCB-induced mouse.
In addition to resveratrol, its methoxylated form
pterostilbene has also shown anti-inﬂammatory
potency for dermatitis treatment. Wang et al. [123]
found that oral pterostilbene (500 mg/kg per day)
attenuated erythema, immune cell inﬁltration and
skin thickness in the chromium-induced allergic
contact dermatitis as seen in the mouse. Pterostilbene suppressed IL-1b and tumor necrosis factor (TNF)-a expression in epidermis induced by
chromium exposure. The cell-based study demonstrated that pterostilbene at 20 mM protected HaCaT
cells against chromium-induced apoptosis and cell
death. Pterostilbene decreased ROS production and
cytokine expression through activation of p38
MAPK signaling pathway. The molecular mechanism associated with inhibition of inﬂammation by
polydatin was elucidated in primary human keratinocytes [124]. Polydatin signiﬁcantly suppressed
lipopolysaccharideand
TNF-a/interferon-ginduced ERK phosphorylation and NF-kB activation, whereas IL-8 was upregulated by this glycoside
under the stimulation of transforming growth factor
(TGF)-a. HaCaT cell lines were activated by TGF-a,
promoting the anti-inﬂammatory mechanism of
polydatin [125]. Polydatin at a dose between 10‒50
mM downregulated monocyte chemotactic protein
(MCP)-1, TNF-a, and IL-6 through ERK pathway.
The cytokines such as TNF-a, IL-6, and IL-8 which
were elevated by heat-stressed HaCaT cells and
reduced with polydatin (44 mM) treatment [126]. All
these data support the fact that polydatin can act as
a potential anti-inﬂammatory agent.
The nanoformulation is a strategy to increase the
anti-inﬂammatory activity of resveratrol. Caddeo et
al. [127] developed the liposomes loaded with both
resveratrol and quercetin for mitigating inﬂammatory and oxidative responses in skin. The liposomes
exhibited a mean diameter of about 80 nm with the
entrapment percentage of >70% in both the compounds. The intracellular concentration in dermal
ﬁbroblasts was increased by 4.4- and 4.7-fold after
liposomal encapsulation of resveratrol and quercetin respectively. TPA treatment on CD-1 mouse
skin caused dry and thickened lesion. TPA-induced
edema was decreased by both compounds, especially the liposomes approaching 50% reduction.
Myeloperoxidase activity was inhibited by 80% after

topical liposome application, indicating an inhibited
neutrophil inﬁltration. Niosomes are nanovesicles
mainly composed of non-ionic surfactants and
cholesterol. These vesicles have a bilayer structure
simulating liposomes. Niosomes can be an alternative of liposomes with the advantage of low cost and
easy large-scale preparation [128]. Resveratrolloaded niosomes were prepared by thin-ﬁlm
method to test anti-inﬂammatory action on skin
[129]. The vesicle size ranged between 214 and 332
nm with an encapsulation efﬁciency of >45%. The
skin deposition as determined by in vitro rat skin
showed an outcome of 4.76 and 0.98 mg/cm2 for
niosomes and aqueous suspension respectively. In
vivo anti-inﬂammatory activity was assessed by
carrageenan-induced paw edema. The percentage
increase of paw volume for niosomal group was
lower than that of saline control group. A prolonged
therapeutic efﬁciency was also observed in the
niosomes. Docosahexaenoic acid (DHA) derived
from marine origin reveals anti-inﬂammatory activity which can be used to treat cardiovascular,
neurodegenerative, and neoplastic disorders [130].
Serini et al [131] found that DHA loaded in resveratrol-containing SLNs could synergize the inhibition of keratinocyte activation. Free DHA at dose of
30 mM suppressed sodium dodecyl sulfate (SDS)induced IL-1b expression in HaCaT cells resulting in
63% inhibition. The inhibition was increased to 80%
by encapsulating into resveratrol-loaded SLNs. A
similar result was detected by using TNF-a as the
stimulator. Resveratrol that was loaded into SLNs
inhibited NOD-, LRR- and pyrin domain-containing
protein 3 (NLRP3) inﬂammasome activation and
enhancing the anti-inﬂammatory effect of DHA. In
the in vivo contact dermatitis model, resveratrol
loaded into SLNs was conﬁrmed to possess the capacity of reducing inﬂammation [132]. SLNs
improved resveratrol delivery into the skin by 3-fold
as compared to that of free compound. The SLNs
are effectively used in the marketed corticosteroid
formulation to restrict edema development. The
anti-inﬂammatory activity of resveratrol and its analogs on keratinocytes or skin is depicted in Table 3.
The effects of resveratrol and its analogs on psoriasis and dermatitis for ameliorating the signs and
symptoms are listed in Fig. 4.
4.5. Hyperpigmentation
Melanin produced by melanocytes gets stored in
melanosomes, after which it is deposited in
epidermis as the determinant of skin color. Despite
the protective effect against sun exposure, abnormal
melanin accumulation leads to several disorders

Table 3. Anti-inﬂammatory activity of resveratrol and its derivatives.
Compound

Experimental model

Cell or animal type

Outcomes offered by the compound

Reference

Resveratrol

In vitro hyperproliferation

Human keratinocytes

[115]

Resveratrol

Balb/c mouse

Resveratrol-enriched rice

In vivo psoriasiform
plaque
In vivo psoriasiform
plaque
In vivo AD-like lesion

NC/Nga mouse

Resveratrol

In vivo AD-like lesion

Balb/c mouse

Resveratrol

In vivo AD-like lesion

Balb/c mouse

Pterostilbene

In vivo contact dermatitislike skin

C57BL/6 mouse

Polydatin

In vitro inﬂammation

Human keratinocytes

Polydatin

In vitro inﬂammation

HaCaT cells

Polydatin

In vitro inﬂammation

HaCaT cells

Resveratrol and quercetin
in liposomes

In vitro uptake and in vivo
inﬂammation

Dermal ﬁbroblasts and
CD-1 mouse

Resveratrol in niosomes

In vitro skin absorption
and in vivo inﬂammation
In vitro inﬂammation

Wistar rat

Resveratrol restrained keratinocyte
proliferation via aquaporin 3
inhibition
Oral resveratrol alleviated the
severity of scaling and skin redness
Topical resveratrol reduced skin
thickness and edema
The rice reduced scratching
frequency and dermatitis severity
Oral resveratrol reduced skin
thickness and immune response
Oral resveratrol downregulated
Th2-type cytokines
Oral pterostilbene attenuated
erythema and immune cell
inﬁltration
Polydatin inhibited ERK
phosphorylation and NF-kB
activation
Polydatin inhibited MCP-1, TNF-a,
and IL-6
Polydatin inhibited TNF-a, IL-6, and
IL-8
The liposomes increased cellular
uptake and reduced edema and
neutrophil inﬁltration
The enhanced resveratrol skin
absorption with reduced edema
DHA could synergize with
resveratrol in SLNs to inhibit
cytokine expression
SLNs inhibited skin edema

Resveratrol

Resveratrol and DHA in
SLNs
Resveratrol in SLNs

In vivo contact dermatitislike skin

Balb/c mouse

HaCaT cells

Mouse

[116]
[118]
[120]
[121]
[122]
[123]

[124]

[125]
[126]
[127]

[129]
[131]

[132]

AD, atopic dermatitis; DHA, docosahexaenoic acid; ERK, extracellular signal-regulated kinase; IL, interleukin; MCP-1, monocyte
chemotactic protein-1; NF-kB, nuclear factor-kB; SLNs, solid lipid nanoparticles; TNF-a, tumor necrosis factor-a.

related to hyperpigmentation, including melasma,
freckle, age spot, and lentigo [133]. Tyrosinase is a
principal enzyme involved in melanogenesis (Fig.
5). Most of the hypopigmenting or skin lightening
agents, especially the natural compounds work on
the mechanism of tyrosinase inhibition [134].
Resveratrol is a direct tyrosinase inhibitor. It also
can inhibit melanogenic enzymes (Fig. 5). Moreover,
it can affect keratinocytes that regulate the function
of melanocytes. Being an antioxidant, resveratrol
prevents keratinocyte-induced melanocyte activation [135]. Park and Boo [136] tested the tyrosinase
inhibition caused by resveratrol. It is noticed that
treatment of human epidermal melanocytes with
tyrosine increased intracellular melanin production.
The melanin synthesis was attenuated by resveratrol at a dose of 3‒100 mM. The HEK293 cells were
transformed to express itself as human tyrosinase. It
is veriﬁed that resveratrol is a strong inhibitor of
human tyrosinase with IC50 of 0.39 mg/ml, which is
lower than p-coumaric acid (0.66 mg/ml) and arbutin

(>100 mg/ml). This skin whitening activity of
resveratrol is certiﬁed in human [137]. In a study the
skin tanning was induced by repetitive UV irradiation on the skin of 15 healthy subjects, followed by
the topical administration of resveratrol. The lightness degree (L*) reduced from 64.2 to 59.3 when
treated with resveratrol for 4 days post-irradiation
as compared to UV irradiation alone, suggesting
that it causes hypopigmentation. Histological assay
supported the inhibition of sunburn cell formation
when resveratrol intervention was implemented.
Some resveratrol analogs have demonstrated
greater capability to inhibit tyrosinase than that
seen with resveratrol. Oxyresveratrol has displayed
inhibitory effects on mushroom tyrosinase with an
IC50 of 1.2 mM, which was 32-fold stronger than kojic
acid [138]. The IC50 of oxyresveratrol for inhibiting
murine tyrosinase activity was 52.7 mM. Mulberry
extract is found to strongly inhibit tyrosinase [139].
Two resveratrol derivatives, namely oxyresveratrol
and 40 -prenyloxyresveratrol were isolated from the
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Fig. 5. The pathogenic mechanisms of skin hyperpigmentation. Melanin synthesis begins with catalysation of the substrates phenylalanine and
tyrosine to produce L-DOPA via tyrosinase. The pathways are then divided into eumelanogenesis or pheomelanogenesis. The other melanogenic
enzyme is TRP-1 for eumelanogenesis. Resveratrol is a direct tyrosinase inhibitor. It also can inhibit melanogenic enzymes.

methanol extract of mulberry leaves [140]. The IC50
of oxyresveratrol and 40 -prenyloxyresveratrol
required to suppress mushroom tyrosinase was 0.57
and 0.90 mM respectively. This inhibitory activity
was stronger than that of arbutin (IC50 ¼ 14.18 mM).
Park et al. [141] has evaluated the anti-melanogenic
potency of oxyresveratrol by using a 3D reconstituted skin model (MelanoDerm®). The reconstituted skin was topically treated with the
compounds at a dose of 125 mmol per tissue. It was
seen that resveratrol and oxyresveratrol lowered
melanin amount to 41% and 65% respectively.
However, the cell viability after undergoing treatment with resveratrol and oxyresveratrol was 20%
and 95% respectively. This outcome suggested that
resveratrol possess high cytotoxicity. In the tyrosinase-transformed HEK293 cell model, oxyresveratrol (IC50 ¼ 0.09 mM) inhibited human
tyrosinase strongly as compared to resveratrol (IC50
¼ 1.8 mM). Besides oxyresveratrol, another hydroxylated resveratrol derivative which causes melanogenesis inhibition is piceatannol. The mushroom

tyrosinase inhibition caused by piceatannol (IC50 ¼
1.53 mM) was higher than that of resveratrol (IC50 ¼
63.2 mM) and kojic acid (IC50 ¼ 50.1 mM) [142].
Piceatannol at a dose of 50 mM decreased melanin
concentration in B16 cells to 14.8%, which was lower
than that of resveratrol (58.4%). Piceatannol also
exhibited a greater inhibition of reactive oxygen
species than that observed with resveratrol.
Jeong et al. [143] explored the inhibitory action of
polydatin on melanogenesis. Polydatin at a dosage of
10, 20 and 50 mg/ml decreased melanin level in
melan-a melanocytes by about 20%, 60% and 70%
respectively. The enzymes related with melanogenesis such as tyrosinase, tyrosinase-related protein
(TRP)-1, and TRP-2 were downregulated by polydatin in a concentration-dependent fashion. The
investigation conducted by Uesugi et al. [144] also
demonstrated a higher degree of mushroom tyrosinase suppression caused by polydatin (IC50 ¼ 14 mM)
as compared with resveratrol (IC50 ¼ 565 mM),
implying that glycosylation has improved tyrosinase
inhibitory effect. Gnetin C is a resveratrol dimer

Table 4. Hypopigmenting activity of resveratrol and its derivatives.
Compound

Experimental model

Cell or animal type

Outcomes offered by the compound

Reference

Resveratrol

Cell-based tyrosinase
inhibition
In vivo UV irradiation

HEK293 cells

Resveratrol was effective to inhibit
human tyrosinase
Resveratrol inhibited sunburn cell
formation
Oxyresveratrol was effective to
inhibit mushroom and murine
tyrosinases
Oxyresveratrol and 40 prenyloxyresveratrol from mulberry
inhibited tyrosinase
Oxyresveratrol showed higher
melanin inhibition than resveratrol
Piceatannol showed higher
tyrosinase inhibition than
resveratrol
Polydatin inhibited melanin content
and tyrosinase
Polydatin showed higher tyrosinase
inhibition than resveratrol
Resveratrol and gnectin showed a
comparable tyrosinase inhibition
a-Viniferin decreased melanin index
in the patients with melasma

[136]

Resveratrol

Human

Oxyresveratrol

Cell-based tyrosinase
inhibition

B16 cells

Oxyresveratrol and 40 prenyloxyresveratrol

In vitro tyrosinase
inhibition

Mushroom tyrosinase

Resveratrol and
oxyresveratrol
Resveratrol and
piceatannol

Cell-based 3D
reconstituted skin
In vitro tyrosinase
inhibition

MelanoDerm®

Polydatin

Cell-based tyrosinase
inhibition
In vitro tyrosinase
inhibition
Cell-based tyrosinase
inhibition
Cell-based tyrosinase
inhibition and in vivo
melasma
In vivo UV irradiation

Melan-a cells

In vitro tyrosinase
inhibition

Mushroom tyrosinase

Polydatin
Resveratrol and gnectin C
a-Viniferin

Resveratrol in
nanoparticles
Resveratrol in SLNs

Mushroom tyrosinase
and B16 cells

Mushroom tyrosinase
B16 cells
Melan-a cells and human

Guinea pig

The nanoparticles decreased
melanin granules in skin
Resveratrol loaded in SLNs
promoted tyrosinase inhibition

[137]
[138]

[140]

[141]
[142]

[143]
[144]
[145]
[146]

[147]
[148]

SLNs, solid lipid nanoparticles; UV, ultraviolet.

which is puriﬁed from melinjo seeds. The inhibitory
potency of gnetin C and resveratrol was shown to be
equally effective against tyrosinase and melanin
biosynthesis as observed in the murine B16 cells
[145]. The IC50 of gnetin C activity against tyrosinase
and melanin biosynthesis was 7.0 and 7.6 mM
respectively, whereas resveratrol exerted IC50 of 7.2
and 7.3 mM respectively. The anti-melanogenesis
response of resveratrol trimer, a-viniferin which is
present in melanocytes and human skin was evaluated in a study conducted by Yun et al. [146].

Treatment performed with a-viniferin in a concentration-dependent manner reduced melanin production in melan-a cells, demonstrating a stronger
activity (>5-fold) than that seen in arbutin. In the
research twenty-three patients who had melasma
and freckles were treated with topically applied
Caragana sinica cream which is rich in a-viniferin.
After 6‒8 weeks it was observed that after the treatment with C. sinica cream there was a decrease in
melanin index and lightening index was increased as

Table 5. Antimicrobial activity of resveratrol and its derivatives.
Compound

Experimental model

Microbial or animal
type

Outcomes offered by the compound

Reference

Resveratrol

In vitro susceptibility

Dermatophytes

[152]

Resveratrol

In vivo skin infection

HSV

Oxyresveratrol

In vivo skin infection

HSV

Pterostilbene

In vitro susceptibility and
in vivo skin infection
In vitro skin absorption
and microbial inhibition

MRSA

Resveratrol effectively retarded
dermatophyte growth
Resveratrol mitigated skin lesion
caused by HSV
Oxyresveratrol delayed the
development of skin lesion caused by
HSV
Pterostilbene showed superior MRSA
growth inhibition than resveratrol
Liposomes improved antimicrobial
activity of resveratrol

Resveratrol and gallic
acid in liposomes

Skin pathogens

HSV, herpes simplex virus; MRSA, methicillin-resistant Staphylococcus aureus.

[155]
[156]

[157]
[158]
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recorded by chromameter. The response was much
better than the vehicle control group.
The resveratrol-enriched rice was grounded to
nano-sized particles by applying high pressure homogenization [147]. The average particle size of the
products was approximately 500 nm. The nanoparticles were topically applied on UVB-exposed
guinea pig skin for 15 days. The results showed that
the color index of UVB-treated skin was 72.2 which
decreased to 55.1 due to the presence of nanoparticles for 15 days. The amount of melanin granules in skin increased by 2.6-fold after UVB
irradiation. This increase was attenuated by 1.6-fold
due to the presence of nanoparticles. The deposition
of resveratrol in skin was dramatically enhanced by
this high pressure homogenization technique.
Resveratrol-loaded SLNs were developed to
examine skin delivery and tyrosinase inhibition
[148]. The prepared nanoformulations had a mean
diameter of <200 nm. It is noticed that up to 45% of
resveratrol could permeate through pig skin from
SLNs. The tyrosinase inhibitory percentage was
increased from 63% to 90% after resveratrol
entrapment into SLNs. An additional advantage of
using the SLNs is that the nanocarriers are non-toxic
towards keratinocytes. It is difﬁcult to compare the
IC50 of resveratrol and its derivatives since the
methodology and experimental setup of different
investigations varies. Table 4 summarizes the
tyrosinase inhibitory or anti-melanogenesis activity
of resveratrol and its derivatives.
4.6. Microbial infection
Microorganisms including viruses, bacteria, fungi
and parasites can cause infectious diseases. Infection-related illness is a leading cause of death
globally [149]. Microbial infection is usually associated with an inﬂammatory response because it activates immune cell defense against the pathogens.
The treatment done with active agents which
possess anti-inﬂammatory and antimicrobial effects
will lead to favorable outcomes and will help in
alleviating many cutaneous conditions. For instance,
more than 90% of AD patients are colonized with
Staphylococcus aureus [150]. The occurrence of S.
aureus has emerged as a predominant threat for AD
treatment. Efﬁcient AD management requires
involvement of multiple drug treatments, including
the immunomodulatory agents or steroids for antiinﬂammation and antibiotics for reducing infection
[151]. Resveratrol is a phytoalexin that helps to
retard the growth of pathogens such as bacteria,
fungi, and viruses [114]. Resveratrol could inhibit
the growth of some dermatophytes, including

Trichophyton mentagrophytes, T. tonsurans, T. rubrum,
Epidermophyton ﬂoccosum, and Microsporum gypseum
[152]. The effective resveratrol concentration to
inhibit growth of these dermatophytes is 110‒220
mM. Resveratrol is reported to bind ATP synthase,
suppressing ATP hydrolysis and synthesis function
to inhibit microbial growth [62]. Resveratrol also
shows antivirulence nature via bioﬁlm reduction,
bacterial motility inhibition, and quorum sensing
interference [153]. At this dose range resveratrol is
expected to not induce cytotoxicity against human
ﬁbroblasts. Along with the antifungal activity,
resveratrol effectively displays anti-herpes simplex
virus (HSV) potency in skin [154]. Docherty et al.
[155] applied topical resveratrol cream (12.5% or
25%) to SKH1 mouse bearing HSV-1 infection. The
results demonstrated that when the treatment
outcome was evaluated 1 and 6 hrs after infection,
both creams effectively suppressed lesion development. The creams are also advantageous to treat
acyclovir-resistant HSV. No erythema, scaling, or
excoriation was observed in the healthy skin which
were treated by resveratrol.
Anti-HSV activity was also found in oxyresveratrol. Chuanasa et al. [156] has evaluated the
therapeutic efﬁciency of topically applied oxyresveratrol on cutaneous HSV infection as observed
in Balb/c mouse. Oxyresveratrol (50 mg/ml) caused
viral inhibitions of 26% and 33% in the infected vero
cells when applied for 3 and 6 hrs respectively. The
combination of resveratrol and acyclovir created a
synergistic anti-HSV-1 response. Topical administration of resveratrol ointment (30%) for ﬁve times
in a day delayed the development of cutaneous
lesion caused by HSV-1. Yang et al. [157] investigated the antibacterial activity of pterostilbene
against methicillin-resistant S. aureus (MRSA) and
the feasibility to treat cutaneous lesion and barrier
dysfunction. The minimum inhibitory concentration
(MIC) assay demonstrated a superior biocidal activity of pterostilbene compared to that of resveratrol (8‒16-fold) against MRSA. Pterostilbene was
found to reduce MRSA bioﬁlm thickness from 18 to
10 mm as detected by confocal microscopy. Pterostilbene increased skin absorption by 6-fold as
compared to resveratrol. Topical pterostilbene
application decreased the abscess formation produced by MRSA by reducing the bacterial burden
and ameliorating the skin architecture. Pterostilbene
demonstrated potent anti-MRSA ability due to the
involvement of various mechanisms. Firstly, it
enhanced bacterial membrane leakage. Secondly, it
caused downregulation of chaperone protein and
upregulated ribosomal protein.

Nanovesicles were used to load resveratrol for
increasing its skin delivery and antimicrobial activity.
Vitonyte et al. [158] loaded both resveratrol and gallic
acid in liposomes to produce vesicles with a size of
around 70 nm. A further incorporation of propylene
glycol or glycerin as the permeation enhancer
increased the size to 170 nm. It was reported that
resveratrol accumulation in the dermal layer of pig
skin was greater for the glycerin-containing liposomes (1%) than that of liposomes and propylene
glycol-containing liposomes (0.4%). An improvement
in antimicrobial activity was shown against skin
pathogens such as S. aureus, S. intermedius, S. pyogenes
and Candida albicans. Table 5 summarizes the antimicrobial activity of resveratrol and its derivatives,
including the design of nanocarriers.

5. Conclusion
The clinical application of resveratrol still poses a
challenge because of its poor solubility, low
bioavailability and the concern of demonstrating
adverse effects. The low bioavailability of resveratrol
can be due to the limited gastrointestinal absorption
and its rapid metabolism. Furthermore, some systemic toxic effects such as headache, somnolence,
blood electrolyte change and rash are observed after
receiving high-dose resveratrol. Topical delivery of
resveratrol can be used as a strategy to avoid the low
oral bioavailability and other possible side effects.
The topical administration is a preferable method to
treat skin-related diseases as discussed in this review. Some of the resveratrol derivatives have
demonstrated superior bioactivity than the parent
compound while treating skin disorders. Although
many resveratrol products are being developed for
testing in cell- and animal-based studies, but clinical
trials for skin application are still limited. This may
be due to the high cost which is required to perform
clinical trials and some unknown side effects that
should be identiﬁed and explored before it is tested
clinically. Further clinical studies are required to
encourage application of resveratrol and its naturally occurring derivatives in the future.
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